NCT01550614View on ClinicalTrials.gov

Efficacy and Safety of Ad5FGF-4 for Myocardial Ischemia in Patients With Stable Angina Due to Coronary Artery Disease

PHASE3TerminatedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

May 31, 2016

Conditions
Angina, Stable
Interventions
GENETIC

Alferminogene tadenovec

One-time intracoronary infusion of Ad5FGF-4 (6x10e9 viral particles in buffer)

Trial Locations (1)

Unknown

Municipal Hospital #15, Moscow

Sponsors
All Listed Sponsors
collaborator

Advanced Biosciences Research

UNKNOWN

lead

Cardium Therapeutics

INDUSTRY

NCT01550614 - Efficacy and Safety of Ad5FGF-4 for Myocardial Ischemia in Patients With Stable Angina Due to Coronary Artery Disease | Biotech Hunter | Biotech Hunter